Literature DB >> 18243064

Interpreting genotype cluster sizes of Mycobacterium tuberculosis isolates typed with IS6110 and spoligotyping.

Fabio Luciani1, Andrew R Francis, Mark M Tanaka.   

Abstract

Molecular techniques such as IS6110-RFLP typing and spacer oligonucleotide typing (spoligotyping) have aided in understanding the transmission patterns of Mycobacterium tuberculosis. The degree of clustering of isolates on the basis of genotypes is informative of the extent of transmission in a given geographic area. We analyzed 130 published data sets of M. tuberculosis isolates, each representing a sample of bacterial isolates from a specific geographic region, typed with either or both of the IS6110-RFLP and spoligotyping methods. We explored common features and differences among these samples. Using population models, we found that the presence of large clusters (typically associated with recent transmission) as well as a large number of singletons (genotypes found exactly once in the data set) is consistent with an expanding infectious population. We also estimated the mutation rate of spoligotype patterns relative to IS6110 patterns and found the former rate to be about 10-26% of the latter. This study illustrates the utility of examining the full distribution of genotype cluster sizes from a given region, in the light of population genetic models.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243064     DOI: 10.1016/j.meegid.2007.12.004

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  8 in total

1.  Inferring epidemiological parameters on the basis of allele frequencies.

Authors:  Tanja Stadler
Journal:  Genetics       Date:  2011-05-05       Impact factor: 4.562

2.  The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis.

Authors:  Fabio Luciani; Scott A Sisson; Honglin Jiang; Andrew R Francis; Mark M Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

3.  Clustering of Mycobacterium tuberculosis cases in Acapulco: Spoligotyping and risk factors.

Authors:  Elizabeth Nava-Aguilera; Yolanda López-Vidal; Eva Harris; Arcadio Morales-Pérez; Steven Mitchell; Miguel Flores-Moreno; Ascencio Villegas-Arrizón; José Legorreta-Soberanis; Robert Ledogar; Neil Andersson
Journal:  Clin Dev Immunol       Date:  2010-12-08

4.  Relative abundance of Mycobacterium bovis molecular types in cattle: a simulation study of potential epidemiological drivers.

Authors:  Hannah Trewby; David M Wright; Robin A Skuce; Carl McCormick; Thomas R Mallon; Eleanor L Presho; Rowland R Kao; Daniel T Haydon; Roman Biek
Journal:  BMC Vet Res       Date:  2017-08-22       Impact factor: 2.741

5.  Molecular epidemiology of Mycobacterium bovis in Cameroon.

Authors:  N F Egbe; A Muwonge; L Ndip; R F Kelly; M Sander; V Tanya; V Ngu Ngwa; I G Handel; A Novak; R Ngandalo; S Mazeri; K L Morgan; A Asuquo; B M de C Bronsvoort
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

6.  Models of deletion for visualizing bacterial variation: an application to tuberculosis spoligotypes.

Authors:  Josephine F Reyes; Andrew R Francis; Mark M Tanaka
Journal:  BMC Bioinformatics       Date:  2008-11-27       Impact factor: 3.169

7.  IS6110 restriction fragment length polymorphism typing of drug-resistant Mycobacterium tuberculosis strains from northeast South Africa.

Authors:  Ezekiel Green; Lawrence C Obi; Anthony I Okoh; Maphoshane Nchabeleng; Babsie E de Villiers; Tomas Letsoalo; Anwar A Hoosen; Pascal O Bessong; Roland N Ndip
Journal:  J Health Popul Nutr       Date:  2013-03       Impact factor: 2.000

8.  A model of tuberculosis clustering in low incidence countries reveals more transmission in the United Kingdom than the Netherlands between 2010 and 2015.

Authors:  Ellen Brooks-Pollock; Leon Danon; Hester Korthals Altes; Jennifer A Davidson; Andrew M T Pollock; Dick van Soolingen; Colin Campbell; Maeve K Lalor
Journal:  PLoS Comput Biol       Date:  2020-03-27       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.